Enews from the Alzheimer's Association

Having trouble viewing this message? You may view it as a web page. You may also view e-news archives.
To prevent mailbox filters from deleting your Alzheimer's Association email communications, please add alzheimers_enews@alz.org to your address book.
October 23, 2019
 
24/7 Helpline: 800.272.3900
Biogen to ask FDA to approve early Alzheimer's disease treatment
Biogen Inc. announced it will seek U.S. Food and Drug Administration (FDA) approval for the experimental drug aducanumab after study results showed it reduced clinical decline in people living with early Alzheimer's. On behalf of the more than 5 million Americans living with Alzheimer's and their family members, the Alzheimer's Association is encouraged that Biogen will pursue regulatory approval for aducanumab.

Click here to read more
Doctor inspires her community through exercise and Alzheimer's education
Dr. Perla Rosales-Garay of the University of California dedicates her time to providing classes on healthy living and exercise to her community, including children, older adults and people living with Alzheimer's. Her advice for those facing the disease is simple: "Never lose hope."
Click here to read more
Online Tools
Your Local Community
 
Reducing stress can help those caring for someone living with Alzheimer's
Alzheimer's caregivers frequently report experiencing high levels of stress. It can be overwhelming to care for someone living with Alzheimer's or another dementia, but making sure you're healthy can help you be a better caregiver.
Click here to read more
Your donations and support make a difference.
More Resources: 
Stages of Alzheimer's  | 
Behaviors  | 
Coping Strategies  | 
Care Training
My Preferences:
Unsubscribe
To stop receiving our weekly e-newsletter, simply unsubscribe.
 
Subscribe
Was this e-newsletter forwarded to you? Subscribe to get it weekly.
The Alzheimer's Association is the leading voluntary health organization in Alzheimer's care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health.

 Alzheimer's Association Home Office 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601
© 2019 Alzheimer's Association. All rights reserved. www.alz.org | 800.272.3900.